Intellipharmaceutics (IPCI) Forum
Sign up Calendar Latest Topics
 
 
 


Reply
  Author   Comment  
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #1 
Well, if my calculations are correct, I believe we should be getting the delisting notice, or I should say notice of another hearing for non-compliance , on Tuesday the 27th.

I suspect the company felt putting out these PR's would be enough to get the price above $1.  I suspect they only had to close above $1 for at least a day.   The regulation is silent on that one.   It just states if you trade below a $1 for 30 consecutive days.  So my guess is the Company hoped by putting out these PR's the price would pop to $1 at least for a day.

I agree they sound suspect.  They do not mention any real details that one can gauge anything.  They do not assign a monetary value, which they easily could because there is a minimum purchase supposedly.  They do not mention who the distributor is so one can verify that the contracts even exist.

Pharmer, I ask again, if you still see the same potential here for the stock?  You keep saying a huge announcement is yet to be made that will skyrocket the price.   what do you do gauge as being "skyrocket" ?    With a current price of $0.53 cents, one could say skyrocket is $1.   I still need around $9.50 a share just to break even!    These latest PR's, which were good news if they are true, didn't move the price up but $0.08 cents!   The last time the company filed the NDA, we didn't even see a price pop, if I recall correctly we may even went down that day, and I believe someone said, its already built into the price because it was a known issue that were going to refile.

Clearly, they claim to have inked an exclusive deal for Rexista (only in the Philippines) and it did not come with any cash. So does this mean we can expect no up front payment if they ink a deal here in the US?   While we have not traded yet after that news was issued because of a holiday, I am not getting a warm fuzzy that we see any pop even near $1 on any news.   But I bet we if we get notice of another delisting hearing we see a drop! 

And people wonder why I say or talk about manipulation.  Either everyone else thinks the PR's are worthless or BS or we were purposefully not even traded properly to see any appreciation or speculative value like any normal company would on good news.   I am just so disgusted as this has ruined me.   Lets just say Thanksgiving was not too thankful.  Most people revert back to "at least you have your health".   I do not even have that.
0
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #2 
Sam- These PRs leave many questions unanswered for me. All I can think is these markets were an afterthought- when things did not go as planned. If the Odidi's had a real market vision, these applications for approval in Vietnam, Malaysia and Philippines would have been submitted years ago. But they appear to just being submitted now. That only goes to show that Odidi has absolutely terrible market vision and he is flailing about like a fish out of water trying to do anything... His years of laziness are catching up with him. Soon he will be a professor at a second rate university. A good place for him to thump his chest and say see how many patents I have... But the question the students need to ask is how much revenue did each of these patents generate?

I now do believe Odidi realizes he has screwed up big time. But he sealed his fate with that last offering. If someone actually wants to take IPCI they can. But at this point it is only for technology grab. Nobody wants to manage that train wreck of a business.
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #3 
Wim, unfortunately I tend to agree and it appears the market does as well.   what should normally have been good news we only went up what 4 cents on 3 PR's?  clearly these were an after thought which is probably why they mentioned in the investor presentation they put out in October that they do not expect international markets to produce revenue for 12 to 24 months.  Heck long before that time he will have blown through this latest toxic offering.  We are just so screwed.   The man spent probably 13 million again this year and we have nothing to show for it.  The offering in October of last year was said because of the HAP studies, so just where did all the money go this year? 
0
nathaly4me

Avatar / Picture

Member
Registered:
Posts: 41
Reply with quote  #4 
I don't think it's all lost yet. Ummm They might have asked for an extension already and if granted, 180 days more of agony are ahead.

With all Purdue/Oxycontin lawsuits around, I wonder what's the December call about?

http://fortune.com/2018/11/19/sackler-family-opioids-lawsuits/
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #5 
Nathaly, not sure what you mean by
Quote:
I wonder what's the December call about?
  I read the article in the link you provided and didn't see anything regarding a call?
as for your other comment about they may ask for another extension.   They already received 2.  Its just another example of how out of touch he is with reality.  when he asked for the last one, he only asked for Oct 17th.   Now, what did he expect to happen?   Here we are a month later.   The panel would look at that and even wonder, why didn't he ask for an extension until year end?  It just goes to show the level of incompetence.  And the worse part is had he stuck to the guidance he gave in January, the HAP studies would have been done and he would have already submitted in September and lord only knows what that would have meant.  No reverse split?  No toxic dilution?  No delisting? People such as myself not ruined?  

At this point mark my words.  While we didn't see any pop on the good news they put out, we will see a drop in price on news that they are out of compliance.  Then when we do pop we go up to what around a $1 and everyone will say, well a pop from 25 cents to a $1 is great.   Oh excuse me a pop to 99 cents.  The manipulation will continue and make sure we head towards delisting and another RS.  This time he will just do a 50 to 1.
0
nathaly4me

Avatar / Picture

Member
Registered:
Posts: 41
Reply with quote  #6 
In October, after September 1/10 reverse split, they received a letter from Nasdaq Listing Qualification notifying that the Company had regained compliance with the minimum bid price requirement. From there, failing to be over $1 during 30 consecutive business days: NEW paperwork for an extension.

The link I provided was only about Purdue's Oxycontin Litigations. Opioids are getting hammered. I've also read about some lawsuits against Walgreens and CVS.

"December call?" well, I was remembering this:
"On October 4, 2018, the parties to the case mutually agreed to postpone the scheduled court date pending a case status conference scheduled for December 17, 2018"
I was kind of hoping for Dec 17 not to be just a random date  Hmmmaybe test/analysis results are done by then...negotiate/drop the case?
Sorry sad just trying to be optimistic
0
fabioulous

Member
Registered:
Posts: 69
Reply with quote  #7 
nathaly4me, your points looks resonsable. The problem is that as Samsa outlined we are currently in the hands of a complete illogical person, being the extension of NASDAQ listing just the last example of how he has no clue of what is going on around him.

the IPCI request to stall the lasuit until 17 dec should under normal circumstances be considered a positive.

but we are under Odidis' circumstances...which is like going into a casinĂ² and playing blinded
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #8 
Nathaly, OK now I understand.   you were referring to the Dec. 17 phone conference with the judge to determine to the case status.    Well the judge admonished IPCI, which is never good, saying this delay is 100% on IPCI.  so if no settlement is reached, the judge will likely extend the 30 month stay.   Yes, under normal circumstances this would lean one to believe that they want to settle the case.  However, as Fabioulous pointed out, this is Odidi.   He hasn't been able to make a deal for Regabatin in 5 years.  He is the type when a lawyer says settle,  its cheaper in the long run, he would rather pay million dollars to try and win then settle for 100k.  Most likely, any partner for Rexista, said settle before we ink any deal.   They do not want that hanging over their heads they want to know all they must deal with is the FDA approval process not Purdue as well.  They would rather give up 5% of profit as a settlement and get selling than be held up in court for years.    The question is that leaves it up to Odidi to settle. 

As for NASDAQ, no it would not be looked at as a "New" delisting hearing.   If you recall part of the original delisting hearing they had to meet three things.   1. market cap of 35 million or share holder equity of 2.5 million.  2. share price above the $1 and 3 a plan to sustain compliance for a year.   So the company is basically on probation for that year.  this would show NASDAQ we couldn't keep compliance but one month which technically they knew we already were not when they sent the letter and made a comment to such.  so they would look at "what did you do to regain compliance in the last months?   Nothing.  They would also look at the item 3 which is clearly then your plan to maintain compliance is flawed.  So if I were the panel, I would say they never complied with item #3 and therefore they lose it.      If he needed additional time he should have requested it back then.  but that's just me and the way I look at it.   I really have no clue how strict NASDAQ is.

so as I was thinking, while we didn't see any price appreciation with good news, watch us get hit when they PR they received notice from NASDAQ.
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #9 
Further thought on why I get disgusted with manipulation.  The company put out 3 PR's which were all positive news.  we saw no price increase except from 47 to 52 cent.  Now, the issues of the problems with those PR's were discussed here in length.   However, conversely, when we got notice of delisting originally we went down in price from $6 range to $4 range.    When we finally received notice of compliance we did not see any price appreciation however.    Now, one can argue that is because in the notice that regained compliance there was a side note that stated, we already were out of compliance and had 30 days to regain.    So technically, its a known fact that we will be receiving a delisting notice again this week.    It's already known, so if so why should we go down in price on an already known event?   Answer we shouldn't, but I bet we do. just wait and see.  This is why I say one is as bad as the other.   Don't get me wrong, Odidi should do what is needed to get us in compliance.  But, the manipulation does not help.  My bet is he felt releasing news of inking deals would have moved us up in price for at least 1 day to stay compliant.  The manipulators want us delisted.  we shall see.  technically we should trade flat for the week.  my gut tells me when they announce Wednesday they have another hearing, we hit a new low.  And we are the ones who suffer.
0
wimuskyfisherman

Moderator
Registered:
Posts: 553
Reply with quote  #10 
Sam- The reason the price cannot and will not go up is because of all the pre-funded warrants and warrants at 75 cents. The last offering basically sent the float from 4.5M to over 20M for $14.5M. And if the additional warrants are exercised, the float will be around 40M and the company only gets about an additional $13M for those 17M shares. Odidi basically sold off 90% of the company at 75 cents per share. He totally blew it and the PPS likely does not recover. Actually, I am guessing, the 75 cent warrants never get exercised as they will likely just do another offering selling shares at 40-50 cents next year...
0
fabioulous

Member
Registered:
Posts: 69
Reply with quote  #11 
Sam, to me the manipulators found in Odidi the perfect idiot for their strategy; they now he cannot do anything good and very often he would do something very wrong.

Any other enterpreneur who loves and believes in his creature would have understand that a listed company has to respect a set of non-written rules . but Odidi said, hey, I am mr scienties with an MBA, I konw what to do.

As wim pointed out many times, likely Boyd will buy the IPCI tech for penauts putting it in the right hands and leaving the Odidis trying to understand how they can fight in court to have (what they thought to be) their IP/patents back.

This is a very sad story, where every single part involved, from Purdue to potential Regabatin partners, from Boyd to Pharmer, from WeeZhul at the AdComm to the FDA generic office, every single part knows and understand it is dealing with an unprepared, unfit, arrogant person (or 2).

I go crazy when I think to all what he did/did not over the last 2 yrs !!
0
Samsa1

Moderator
Registered:
Posts: 692
Reply with quote  #12 
Fabioulous, today is a prime example.  the market knows we got approval for Effexor.  we currently sit at 11 million shares but only up 10 cents!  why?  because the company has not PR'd it.   So sad.   They blow good news! what should have popped us to $1 won't. 

John I hear you about the last offering but while that offering effects our potential, we still only have around 8 million actual float.  I would think something like todays approval should have popped us up to at least $1.  But I hear you about the effect of the offering.   If that is true and we cant get back to $1 then how the hell did he ever expect to meet compliance?   we have no way too.
0
Previous Topic | Next Topic
Print
Reply

Quick Navigation:

Easily create a Forum Website with Website Toolbox.